A Lean Mass Hyper-Responder and Researcher Shares his Personal Experience - Nick Norwitz, PhD

Описание: The Keto-CTA study examining Lean Mass Hyper-Responders (LMHRs), LDL cholesterol levels, and coronary plaque progression has quickly become a hot topic of discussion across scientific and social media communities.

In this interview, we speak with Dr. Nick Norwitz—one of the study’s co-authors and a LMHR himself—who helps unpack some of the swirling debates and clarify misconceptions that have surfaced online.

Dr. Norwitz shares a personal perspective: he himself is a LMHR, with LDL cholesterol levels exceeding 500 mg/dL. That fact alone has placed him at the center of the controversy. Yet, as he thoughtfully explains, “I have more reason than anyone to not get this wrong.”

A central question in this conversation: Are LMHRs inherently protected from cardiovascular disease? Dr. Norwitz emphasizes that the answer is not one-size-fits-all. Due to the diversity within the LMHR phenotype, individual context matters.

For Dr. Norwitz, ketogenic therapy has been life-changing, placing his inflammatory bowel disease into remission and allowing him to remain off medications. With no evidence of coronary plaque on CTA, he believes that continuing his ketogenic lifestyle without lipid-lowering medications is the right path for him. But he is clear: the findings from the study do not suggest that all LMHRs are protected.

💡 Key topics include:

Interpreting the KETO CTA study from a personalized perspective
Coronary CT angiography and assessing true cardiovascular risk
Plaque progression in the Keto-CTA study
Addressing biases
The need for rigorous science and individualized patient-centered care
New papers with more data are in the works

This conversation is a reminder of the importance of personalized care, the need for ongoing research, and the humility required when challenging the status quo.

Expert Featured:
Dr. Nick Norwitz
X: https://x.com/nicknorwitz?lang=en
YouTube:    / @nicknorwitzmdphd  
Instagram: https://www.instagram.com/nicknorwitz...

Resources Mentioned:
Plaque Begets Plaque, ApoB Does Not: Longitudinal Data From the KETO-CTA Trial
https://www.jacc.org/doi/10.1016/j.ja...

Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research
https://www.lipidjournal.com/article/...

CMEs Mentioned:
Managing Major Mental Illness with Dietary Change: The New Science of Hope
https://www.mycme.com/courses/managin...

Brain Energy: The Metabolic Theory of Mental Illness
https://www.mycme.com/courses/brain-e...

Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.

Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/

About us:
Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.

Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

Timestamps:
0:00 - Introduction to Nick Norwitz’s relationship to the Keto-CTA study
4:32 - Is it safe to be a Lean Mass Hyper Responder according to the study? How does underlying plaque affect this interpretation?
9:05 - How does the paper’s conclusions affect treatment of individuals?
12:05 - What other data from the study will be used in further papers?
16:40 - Response to the criticisms of the study and its interpretations